SMTL ID : 9h66.1 (2 other biounits)

Steroidal Selective Modulators of FXR with Therapeutic Potential

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-2-3-mer

Ligands

2 x R3U: (4~{R})-4-[(3~{R},4~{R},5~{S},6~{R},7~{R},8~{S},9~{S},10~{R},13~{R},14~{R},17~{R})-6-ethyl-4-fluoranyl-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]-~{N}-[4-(trifluoromethyloxy)phenyl]sulfonyl-pentanamide(Non-covalent)(Covalent)

R3U.1: 27 residues within 4Å: Chain A: Y.21, R.25, M.26, L.48, M.51, A.52, N.54, H.55, V.58, L.59, F.62, M.89, F.90, R.92, S.93, I.96, I.113, I.118, Y.122, I.123, M.126, F.127, Y.130, T.147, H.208, M.211, W.215 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.48, A:V.58, A:I.113, A:I.113, A:I.118, A:I.123, A:F.127, A:W.215, A:W.215 Hydrogen bonds: A:M.26, A:N.54, A:R.92, A:S.93, A:S.93, A:H.208 Halogen bonds: A:Y.21 R3U.2: 24 residues within 4Å: Chain B: Y.21, R.25, M.26, L.48, M.51, A.52, H.55, V.58, L.59, F.62, M.89, F.90, R.92, S.93, I.96, I.113, I.118, Y.122, I.123, M.126, Y.130, T.147, H.208, W.215 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:L.48, B:H.55, B:V.58, B:I.96, B:I.113, B:I.118, B:I.123, B:W.215 Hydrogen bonds: B:M.26, B:R.92, B:R.92, B:S.93, B:S.93, B:Y.122, B:Y.130, B:H.208 Halogen bonds: B:Y.21

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kydd-Sinclair, D. et al., Structural Basis of Novel Bile Acid-Based Modulators of FXR. J.Mol.Biol. (2025)

Release Date

2025-09-10

Peptides

Bile acid receptor: AB
Nuclear receptor coactivator 2: CDE

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
E

D
F

E
G

Bile acid receptor

Nuclear receptor coactivator 2

Related Entries With Identical Sequence